ASX - By Stock
|
PVL |
Re:
Ann: 1H FY24 Results Presentation
|
|
Halo99
|
8 |
1.3K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
PVL |
Re:
Ann: 1H FY24 Results Presentation
|
|
Halo99
|
8 |
1.3K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
GNX |
Re:
Ann: Genex receives NBIO from J-POWER
|
|
Halo99
|
101 |
35K |
7 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
101
|
35K
|
7
|
|
ASX - By Stock
|
PVL |
Re:
Ann: 1H FY24 Results Presentation
|
|
Halo99
|
8 |
1.3K |
0 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
8
|
1.3K
|
0
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
Halo99
|
3.1K |
881K |
13 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
3.1K
|
881K
|
13
|
|
ASX - By Stock
|
GNX |
Re:
Ann: Genex achieves energisation of Bouldercombe Battery Project
|
|
Halo99
|
80 |
29K |
3 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
80
|
29K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Halo99
|
29 |
9.8K |
3 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
29
|
9.8K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
Halo99
|
224 |
52K |
11 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
224
|
52K
|
11
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
Halo99
|
74 |
16K |
10 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
74
|
16K
|
10
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
Halo99
|
523 |
91K |
7 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
523
|
91K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Halo99
|
241 |
46K |
3 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
241
|
46K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Halo99
|
506 |
91K |
0 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
506
|
91K
|
0
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Added Funding for 2023
|
|
Halo99
|
46 |
18K |
4 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
46
|
18K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Halo99
|
241 |
46K |
1 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
241
|
46K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Halo99
|
241 |
46K |
4 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
241
|
46K
|
4
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Halo99
|
14 |
6.9K |
5 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
14
|
6.9K
|
5
|
|
ASX - By Stock
|
GNX |
Re:
GNX a speculative buy MORGANS
|
|
Halo99
|
23 |
11K |
3 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
23
|
11K
|
3
|
|
ASX - By Stock
|
EX1 |
Re:
Would love to hear from some long termers
|
|
Halo99
|
12 |
4.7K |
4 |
08/01/23 |
08/01/23 |
ASX - By Stock
|
12
|
4.7K
|
4
|
|
ASX - By Stock
|
PVL |
Re:
Ann: Change of Director's Interest Notice
|
|
Halo99
|
22 |
8.7K |
2 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
22
|
8.7K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Appendix 3G - Tranche 2 Convertible Note
|
|
Halo99
|
1 |
1.0K |
10 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
1
|
1.0K
|
10
|
|
ASX - By Stock
|
PVL |
Re:
Ann: Change of Director's Interest Notice
|
|
Halo99
|
22 |
8.7K |
1 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
22
|
8.7K
|
1
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Operations review, Board and other changes
|
|
Halo99
|
13 |
6.6K |
4 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
13
|
6.6K
|
4
|
|
ASX - By Stock
|
GNX |
Re:
Ann: Conclusion of discussions with Skip Capital and Stonepeak
|
|
Halo99
|
18 |
11K |
3 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
18
|
11K
|
3
|
|
ASX - By Stock
|
GNX |
Re:
Ann: Conclusion of discussions with Skip Capital and Stonepeak
|
|
Halo99
|
18 |
11K |
4 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
18
|
11K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
Halo99
|
506 |
91K |
2 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
506
|
91K
|
2
|
|
ASX - By Stock
|
PAC |
Re:
Ann: Change in substantial holding
|
|
Halo99
|
15 |
4.5K |
3 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
15
|
4.5K
|
3
|
|
ASX - By Stock
|
PAC |
Re:
Ann: Change in substantial holding
|
|
Halo99
|
15 |
4.5K |
3 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
15
|
4.5K
|
3
|
|
ASX - By Stock
|
PVL |
Re:
Ann: Portfolio Update
|
|
Halo99
|
10 |
3.3K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
10
|
3.3K
|
1
|
|
ASX - By Stock
|
PVL |
Re:
Ann: Portfolio Update
|
|
Halo99
|
10 |
3.3K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
10
|
3.3K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Approval for Paediatric Plan from the EMA
|
|
Halo99
|
132 |
20K |
1 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
132
|
20K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Approval for Paediatric Plan from the EMA
|
|
Halo99
|
132 |
20K |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
132
|
20K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Approval for Paediatric Plan from the EMA
|
|
Halo99
|
132 |
20K |
2 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
132
|
20K
|
2
|
|
ASX - By Stock
|
GNX |
Re:
RED ALERT - GENEX INDEPENDENT LEGAL OPINION ON THE PRIVATISATION TAKEOVER BY FARQUHAR/JACKSON.
|
|
Halo99
|
18 |
9.7K |
12 |
18/12/22 |
18/12/22 |
ASX - By Stock
|
18
|
9.7K
|
12
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
Halo99
|
55 |
9.7K |
2 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
55
|
9.7K
|
2
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Clarification Announcement
|
|
Halo99
|
160 |
34K |
10 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
160
|
34K
|
10
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Upcoming Conference Presentation ANZSEV2022
|
|
Halo99
|
16 |
9.2K |
7 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
16
|
9.2K
|
7
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Brickworks Collaboration Progresses to Development Stage
|
|
Halo99
|
52 |
14K |
6 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
52
|
14K
|
6
|
|
ASX - By Stock
|
PAC |
Re:
Ann: Funds under management as at 30 June 2022
|
|
Halo99
|
29 |
6.0K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
29
|
6.0K
|
3
|
|
ASX - By Stock
|
PAC |
Re:
Ann: Funds under management as at 30 June 2022
|
|
Halo99
|
29 |
6.0K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
29
|
6.0K
|
3
|
|
ASX - By Stock
|
PAC |
Re:
Ann: Funds under management as at 30 June 2022
|
|
Halo99
|
29 |
6.0K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
29
|
6.0K
|
3
|
|
ASX - By Stock
|
SMN |
Re:
EGM imbroglio and probable placement
|
|
Halo99
|
3 |
1.2K |
10 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
3
|
1.2K
|
10
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Halo99
|
17 |
7.5K |
10 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
17
|
7.5K
|
10
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Halo99
|
17 |
7.5K |
5 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
17
|
7.5K
|
5
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Halo99
|
17 |
7.5K |
13 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
17
|
7.5K
|
13
|
|
ASX - By Stock
|
GNX |
Re:
General GNX News
|
|
Halo99
|
2.2K |
800K |
3 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
2.2K
|
800K
|
3
|
|
ASX - By Stock
|
GNX |
Re:
General GNX News
|
|
Halo99
|
2.2K |
800K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
2.2K
|
800K
|
1
|
|
ASX - By Stock
|
GNX |
Re:
General GNX News
|
|
Halo99
|
2.2K |
800K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
2.2K
|
800K
|
2
|
|
ASX - By Stock
|
KYK |
Re:
Ann: Becoming a substantial holder
|
|
Halo99
|
3 |
1.9K |
2 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: DEL Enters Landmark Collaboration Agreement with Brickworks
|
|
Halo99
|
137 |
48K |
5 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
137
|
48K
|
5
|
|
ASX - By Stock
|
DEL |
Re:
Ann: DEL Enters Landmark Collaboration Agreement with Brickworks
|
|
Halo99
|
137 |
48K |
1 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
137
|
48K
|
1
|
|